SPDL1 and neoplasm: In a meta-analysis of 1162 patients across 11 studies, high circulating sPD-L1 levels were significantly correlated with inferior overall survival (OS) and progression-free survival (PFS), irrespective of PD-L1 expression in tumor tissue [52].